Enhanced contractile response to thrombin in the pregnant rat myometrium

Br J Pharmacol. 2000 Dec;131(8):1619-28. doi: 10.1038/sj.bjp.0703729.

Abstract

Thrombin causes various cellular events by activating protease-activated receptors (PARs). Here, we showed, for the first time, that thrombin induced myometrial contraction. To determine the mechanism of thrombin-induced myometrial contraction, we simultaneously measured intracellular Ca(2+) concentration ([Ca(2+)](i)) and tension of fura-PE3-loaded rat myometrium using front-surface fluorimetry. The expression of thrombin receptor mRNA in the rat myometrium were determined by reverse transcription-polymerase chain reaction analysis (RT - PCR analysis). Thrombin (0.01 - 3 u ml(-1)) caused dose-dependent increase in [Ca(2+)](i) and tension in the rat myometrium, and this effect was greatly enhanced in the pregnant myometrium. PAR1-activating peptide mimicked the effects of thrombin. In Ca(2+)-free PSS, thrombin induced no increase in [Ca(2+)](i) and tension in the pregnant myometrium. Both diltiazem (10 microM) and SK-F 96365 (10 microM) significantly inhibited the thrombin-induced elevations of [Ca(2+)](i) and tension, and their effects were additive. RT - PCR analysis revealed an approximately 10 fold increase in the level of thrombin receptor mRNA in the pregnant myometrium compared to that obtained in the non-pregnant myometrium. In conclusion, the contractile response to thrombin was greatly enhanced in the pregnant myometrium, mainly due to the up-regulation of thrombin receptor. We propose that initiation of a post-parturitional myometrial contraction is one of the most important physiological roles of thrombin receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Fluorometry
  • Gene Expression Regulation / drug effects
  • Gestational Age
  • Humans
  • In Vitro Techniques
  • Muscle Contraction / drug effects*
  • Myometrium / drug effects*
  • Myometrium / metabolism
  • Myometrium / physiology
  • Peptide Fragments / pharmacology
  • Phenylmethylsulfonyl Fluoride / analogs & derivatives*
  • Phenylmethylsulfonyl Fluoride / pharmacology
  • Potassium / pharmacology
  • Pregnancy
  • Protease Inhibitors / pharmacology
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Inbred WKY
  • Receptor, PAR-1
  • Receptors, Thrombin / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thrombin / pharmacology*
  • Time Factors

Substances

  • Peptide Fragments
  • Protease Inhibitors
  • RNA, Messenger
  • Receptor, PAR-1
  • Receptors, Thrombin
  • thrombin receptor peptide SFLLRNP
  • Phenylmethylsulfonyl Fluoride
  • (4-amidinophenyl)methanesulfonyl fluoride
  • Thrombin
  • Potassium
  • Calcium